Sparo Labs is an award-winning, digital health company in St. Louis committed to transforming care for individuals with asthma from reactive to proactive.
30 million people in the United States have asthma. For children, asthma is the #1 condition causing ER visits, hospitalizations, and missed school. Sparo Labs’ flagship product, Wing®, is the first FDA-cleared, OTC smartphone sensor to measure lung function – empowering patients to proactively control asthma. Core hardware & software technologies are patent-pending, and over 600 Wings have been shipped to patients since receiving FDA clearance.